HRS-1893 - Jiangsu Hengrui Pharma
Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function (clinicaltrials.gov) - Sep 11, 2025 - P1 | N=24 | Completed | Sponsor: Shandong Suncadia Medicine Co., Ltd. | Recruiting ➔ Completed 
Trial completion • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Nephrology • Renal Disease
http://clinicaltrials.gov/ct2/show/NCT06775834
 
Sep 11, 2025
 
Prev Next